Arkolith/Insider Trading/AQST/Form 4

Wargacki Stephen

Chief Science OfficerAquestive Therapeutics, Inc. (AQST) · full profile →Form 4 · filed Mar 11, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 10, 2025Tax withholding(F)5K$2.54$12K344K
Mar 9, 2025Tax withholding(F)15K$2.65$41K348K
Mar 7, 2025Grant(A)115K—$0376K
Mar 7, 2025Tax withholding(F)13K$2.65$34K364K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 7, 2025Grant(A)65K—$065K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214659-25-004228) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML